EBS icon

Emergent Biosolutions

160 hedge funds and large institutions have $176M invested in Emergent Biosolutions in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

1% less call options, than puts

Call options by funds: $944K | Put options by funds: $956K

47% less capital invested

Capital invested by funds: $332M → $176M (-$156M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
160
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$944K
Puts
$956K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.93M
27
$1.82M
28
$1.81M
29
$1.73M
30
$1.63M
31
$1.43M
32
$1.36M
33
$1.34M
34
$1.32M
35
$1.11M
36
$1.04M
37
$1.04M
38
$954K
39
$911K
40
$794K
41
$771K
42
$723K
43
$717K
44
$713K
45
$695K
46
$674K
47
$663K
48
$545K
49
$540K
50
$526K